
MS Drug — Ampyra: A New Gait For Independence
Circa 2010 In January 2010, the US Federal Drug Administration (FDA) approved AMPRYA (dalfampridine) extended release tablets to improve walking capabilities for patients with multiple schlerosis (MS). In clinical trials, patients who took AMPYRA had …